Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis

Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2016/06/15, Vol.55(12), pp.1661-1665
Hauptverfasser: Kikuchi, Jun, Kaneko, Yuko, Kasahara, Hidenori, Emoto, Katsura, Kubo, Akiharu, Okamoto, Shinichiro, Takeuchi, Tsutomu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1665
container_issue 12
container_start_page 1661
container_title Internal Medicine
container_volume 55
creator Kikuchi, Jun
Kaneko, Yuko
Kasahara, Hidenori
Emoto, Katsura
Kubo, Akiharu
Okamoto, Shinichiro
Takeuchi, Tsutomu
description Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.
doi_str_mv 10.2169/internalmedicine.55.6943
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808616206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1797537363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</originalsourceid><addsrcrecordid>eNqFkUtP4zAQx60VaFseXwH5yCXFj9hJjoDYBakIhHbP1sSZNEZ5FNthl29PqpYeEBKXmZHmN88_IZSzheC6uHB9RN9D22HlrOtxodRCF6n8QeZcpkWSCakOyJwVPE_EZGbkKIRnxmSeFeInmYlMMq5EOiflPcZmiB7_Q8QEQhism6KK3vXRwysEO7bg6RL8CulVYrFt6fKtWzdDB9T1FOgjRId9pP9cbOhTg2MHcXAVvfSx8S66cEIOa2gDnu78Mfn76-bP9W2yfPh9d325TKzSLCZpLRUiF1JiqXLFkOep4oW2vKpFmpaVrnVl2cQKFGVZ2BQ5gyqbbpKCCyWPyfm279oPLyOGaDoXNgtDj8MYDM9ZrrkWTH-PZkWmZCa1nNB8i1o_hOCxNmvvOvBvhjOzEcN8FsMoZTZiTKVnuyljOSX3hR_fn4CHLfAcIqxwD4CPzrb4ZWcuNnY3Yk_aBrzBXr4DRvyoWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1797537363</pqid></control><display><type>article</type><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</creator><creatorcontrib>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</creatorcontrib><description>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.55.6943</identifier><identifier>PMID: 27301524</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Arthritis, Rheumatoid - drug therapy ; Female ; Humans ; intravascular lymphoma ; Japan ; Lymphoma, B-Cell - chemically induced ; Lymphoma, B-Cell - drug therapy ; Lymphoma, Large B-Cell, Diffuse - chemically induced ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoproliferative Disorders - chemically induced ; Lymphoproliferative Disorders - drug therapy ; methotrexate ; Methotrexate - adverse effects ; Methotrexate - therapeutic use ; Middle Aged ; Remission Induction ; rheumatoid arthritis ; spontaneous regression</subject><ispartof>Internal Medicine, 2016/06/15, Vol.55(12), pp.1661-1665</ispartof><rights>2016 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</citedby><cites>FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27301524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kikuchi, Jun</creatorcontrib><creatorcontrib>Kaneko, Yuko</creatorcontrib><creatorcontrib>Kasahara, Hidenori</creatorcontrib><creatorcontrib>Emoto, Katsura</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Okamoto, Shinichiro</creatorcontrib><creatorcontrib>Takeuchi, Tsutomu</creatorcontrib><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</description><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>intravascular lymphoma</subject><subject>Japan</subject><subject>Lymphoma, B-Cell - chemically induced</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - chemically induced</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoproliferative Disorders - chemically induced</subject><subject>Lymphoproliferative Disorders - drug therapy</subject><subject>methotrexate</subject><subject>Methotrexate - adverse effects</subject><subject>Methotrexate - therapeutic use</subject><subject>Middle Aged</subject><subject>Remission Induction</subject><subject>rheumatoid arthritis</subject><subject>spontaneous regression</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtP4zAQx60VaFseXwH5yCXFj9hJjoDYBakIhHbP1sSZNEZ5FNthl29PqpYeEBKXmZHmN88_IZSzheC6uHB9RN9D22HlrOtxodRCF6n8QeZcpkWSCakOyJwVPE_EZGbkKIRnxmSeFeInmYlMMq5EOiflPcZmiB7_Q8QEQhism6KK3vXRwysEO7bg6RL8CulVYrFt6fKtWzdDB9T1FOgjRId9pP9cbOhTg2MHcXAVvfSx8S66cEIOa2gDnu78Mfn76-bP9W2yfPh9d325TKzSLCZpLRUiF1JiqXLFkOep4oW2vKpFmpaVrnVl2cQKFGVZ2BQ5gyqbbpKCCyWPyfm279oPLyOGaDoXNgtDj8MYDM9ZrrkWTH-PZkWmZCa1nNB8i1o_hOCxNmvvOvBvhjOzEcN8FsMoZTZiTKVnuyljOSX3hR_fn4CHLfAcIqxwD4CPzrb4ZWcuNnY3Yk_aBrzBXr4DRvyoWw</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kikuchi, Jun</creator><creator>Kaneko, Yuko</creator><creator>Kasahara, Hidenori</creator><creator>Emoto, Katsura</creator><creator>Kubo, Akiharu</creator><creator>Okamoto, Shinichiro</creator><creator>Takeuchi, Tsutomu</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160101</creationdate><title>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</title><author>Kikuchi, Jun ; Kaneko, Yuko ; Kasahara, Hidenori ; Emoto, Katsura ; Kubo, Akiharu ; Okamoto, Shinichiro ; Takeuchi, Tsutomu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-4f35ee1233eb5850e1845196c1df244bd6f6dc05602e2bb9c4e10ad7387321253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>intravascular lymphoma</topic><topic>Japan</topic><topic>Lymphoma, B-Cell - chemically induced</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - chemically induced</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoproliferative Disorders - chemically induced</topic><topic>Lymphoproliferative Disorders - drug therapy</topic><topic>methotrexate</topic><topic>Methotrexate - adverse effects</topic><topic>Methotrexate - therapeutic use</topic><topic>Middle Aged</topic><topic>Remission Induction</topic><topic>rheumatoid arthritis</topic><topic>spontaneous regression</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kikuchi, Jun</creatorcontrib><creatorcontrib>Kaneko, Yuko</creatorcontrib><creatorcontrib>Kasahara, Hidenori</creatorcontrib><creatorcontrib>Emoto, Katsura</creatorcontrib><creatorcontrib>Kubo, Akiharu</creatorcontrib><creatorcontrib>Okamoto, Shinichiro</creatorcontrib><creatorcontrib>Takeuchi, Tsutomu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kikuchi, Jun</au><au>Kaneko, Yuko</au><au>Kasahara, Hidenori</au><au>Emoto, Katsura</au><au>Kubo, Akiharu</au><au>Okamoto, Shinichiro</au><au>Takeuchi, Tsutomu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>55</volume><issue>12</issue><spage>1661</spage><epage>1665</epage><pages>1661-1665</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>27301524</pmid><doi>10.2169/internalmedicine.55.6943</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2016/06/15, Vol.55(12), pp.1661-1665
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_1808616206
source J-STAGE Free; MEDLINE; PubMed Central Open Access; PubMed Central
subjects Arthritis, Rheumatoid - drug therapy
Female
Humans
intravascular lymphoma
Japan
Lymphoma, B-Cell - chemically induced
Lymphoma, B-Cell - drug therapy
Lymphoma, Large B-Cell, Diffuse - chemically induced
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoproliferative Disorders - chemically induced
Lymphoproliferative Disorders - drug therapy
methotrexate
Methotrexate - adverse effects
Methotrexate - therapeutic use
Middle Aged
Remission Induction
rheumatoid arthritis
spontaneous regression
title Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methotrexate-associated%20Intravascular%20Large%20B-cell%20Lymphoma%20in%20a%20Patient%20with%20Rheumatoid%20Arthritis&rft.jtitle=Internal%20Medicine&rft.au=Kikuchi,%20Jun&rft.date=2016-01-01&rft.volume=55&rft.issue=12&rft.spage=1661&rft.epage=1665&rft.pages=1661-1665&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.55.6943&rft_dat=%3Cproquest_cross%3E1797537363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1797537363&rft_id=info:pmid/27301524&rfr_iscdi=true